Identity
- Trade Name
- LIAISON XL MUREX Control HIV Ab/Ag HT FDA UDI
- Generic Name
- HIV1/HIV2 antigen/antibody IVD, control FDA UDI
- Model / Reference
- 318291 FDA UDI
Identifiers
- Primary DI / UDI-DI
- 08056771500234 FDA UDI
- GMDN Term
- HIV1/HIV2 antigen/antibody IVD, control FDA UDI
Classification
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
Yes
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
Yes
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
Yes
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
No
FDA UDI
Lot / Batch Number
Yes
FDA UDI
Serial Number
No
FDA UDI
Expiration Date
Yes
FDA UDI
Manufacturing Date
No
FDA UDI
Category: HIV1/HIV2 antigen/antibody IVD, control
LIAISON XL MUREX Control HIV Ab/Ag HT by Diasorin S.P.A — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as HIV1/HIV2 antigen/antibody IVD, control.
- PreciControl HIV Gen II — Roche Diagnostics Corp. · Class I
- PreciControl HIV; HIV-2 + GrpO — Roche Diagnostics Corp. · Class I
- GS — Bio-Rad Laboratories · Class II
- PreciControl Release HIV Gen II — Roche Diagnostics Corp. · U
- Alinity — Abbott
- Alinity — Abbott
- ACCESS HIV Ag/Ab combo QC — Beckman Coulter, Inc. · Class I
- BioPlex® 2200 — Bio-Rad Laboratories · Class II
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | N/A | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Diasorin S.P.A
Sources (1)
- FDA UDI 1d41c837-d8c0-4134-a3b5-d517e5aab072 32 fields · synced May 30, 2026